Learn in this In Vivo article how a proposed new approach to value-based contracts could help drive the shift to value-based reimbursements and drug pricing.
Value-based healthcare and Value Labs
Cost of Capital- India Survey for the Lifesciences sector
Life sciences dealmaking expected to continue
Australia’s diverted profits tax
Cracking the engaged aging code through technology
Global Corporate Divestment Study: Life sciences
The 2017 outlook for life sciences
It’s time to bring drug pricing down
Do India’s growth opportunities outweigh the market challenges?
Life Sciences Industry
Life Sciences Consulting Services
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas: